Pyrophosphatase Inorganic (yeast)
Pyrophosphatase Inorganic (yeast) - M (Molecular Biology) / Non-GMP / 0.1kU / centrifuge tube is backordered and will ship as soon as it is back in stock.
Couldn't load pickup availability
Shipping notes
Shipping notes
Products in shop.hongene.com currently can only ship to the United States and Canada. For other regions, please visit contact us page to leave us a message or contact our regional sales.
Processing Time: within 2 business days, if available.
Delivery Time:- US: 3-8 business days (FedEx Standard).
- Canada: 5-10 business days (excludes customs delays).
Note: Delays due to force majeure like customs, natural disasters, or strikes are beyond our liability.
Excerpt from Shipping Policy
Related Products
Details
Details
Product Information
Product description: PPase is prepared from an E. coli strain containing Saccharomyces cerevisiae ppa gene. It is a homodimer consisting of two equal subunits of molecular weight 32-35kDa. The enzyme catalyzes the hydrolysis of inorganic pyrophosphate into two orthophosphates.
Source: Recombinant E.coli
Concentration: 0.1U/μL
Unit Definition: One unit is the amount of enzyme that will generate 1 μmol of phosphate per minute from inorganic pyrophosphate under standard reaction conditions (a 10 minute reaction at 25℃ in 100mM Tris-HCl, [pH 7.2], 2mM MgCl2 and 2mM PPi in a reaction volume of 0.5mL)
Storage Buffer: 20mM Tris-HCl PH8.0, 1mM DTT, 0.1mM EDTA, 50% Glycerol.
Key points of operation
When in vitro transcription, higher yields of RNA may be obtained by adding inorganic pyrophosphatase to a final concentration of 4units/mL.
Security Information
Storage Conditions: -20℃
Quality Assurance: Free of endonuclease, exonuclease and RNase activities.
Physical Purity: >95% by SDS-PAGE.
Reference
1. Cooperman, B.S., The mechanism of action of yeast inorganic pyrophosphatase, Meth. Enzymol., 87, 526-548, 1982.
2. Cunningham, P.R. and Ofengand, J., Use of inorganic pyrophosphatase to improve the yield of in vitro transcription reactions catalyzed by T7 RNA polymerase, Biotechniques, 9, 713-714, 1990.
Specifications
Specifications
-
Catalog No.ON-025ON-025-G
-
SourceRecombinant E.coliRecombinant E.coli
-
Purity>95% by SDS-PAGE>95% by SDS-PAGE
-
Storage Condition-20℃-20℃
Documentation
Documentation
Product Information
Product description: PPase is prepared from an E. coli strain containing Saccharomyces cerevisiae ppa gene. It is a homodimer consisting of two equal subunits of molecular weight 32-35kDa. The enzyme catalyzes the hydrolysis of inorganic pyrophosphate into two orthophosphates.
Source: Recombinant E.coli
Concentration: 0.1U/μL
Unit Definition: One unit is the amount of enzyme that will generate 1 μmol of phosphate per minute from inorganic pyrophosphate under standard reaction conditions (a 10 minute reaction at 25℃ in 100mM Tris-HCl, [pH 7.2], 2mM MgCl2 and 2mM PPi in a reaction volume of 0.5mL)
Storage Buffer: 20mM Tris-HCl PH8.0, 1mM DTT, 0.1mM EDTA, 50% Glycerol.
Key points of operation
When in vitro transcription, higher yields of RNA may be obtained by adding inorganic pyrophosphatase to a final concentration of 4units/mL.
Security Information
Storage Conditions: -20℃
Quality Assurance: Free of endonuclease, exonuclease and RNase activities.
Physical Purity: >95% by SDS-PAGE.
Reference
1. Cooperman, B.S., The mechanism of action of yeast inorganic pyrophosphatase, Meth. Enzymol., 87, 526-548, 1982.
2. Cunningham, P.R. and Ofengand, J., Use of inorganic pyrophosphatase to improve the yield of in vitro transcription reactions catalyzed by T7 RNA polymerase, Biotechniques, 9, 713-714, 1990.
-
Catalog No.ON-025ON-025-G
-
SourceRecombinant E.coliRecombinant E.coli
-
Purity>95% by SDS-PAGE>95% by SDS-PAGE
-
Storage Condition-20℃-20℃
Why choose Hongene?
Trusted Partner in Nucleic Acid
Integrated Supply & Commercial Scale
With 26+ years of expertise, we control a secure supply chain for RNA raw materials and provide reliable GMP-grade oligo synthesis from research to commercial kilogram-scale production.
Proprietary Technology & IP
Our proprietary Chemoenzymatic Ligation Platform combines chemical andenzymatic methods, enabling high-putity, cost-effective, and large-scale production of RNA-based therapeutics.
Rigorous Quality
We implement multiple stringent QC steps, maintain ISO certifications, and ensure >99% batch-to-batch consistency, reducing scale-up and PPQ risks.
Manufacturing Scalability
Hongene operates 1.67 million sq. ft Oligonucleotide Manufacturing Facility, with advanced equipments including multiple OligoPilot™ and OligoProcess™ synthesizers (10-1800 mmol). 48 flexible production lines enable one-stop seamless scaling-up of API production from gram-level to tons and acheive high purity of 98%, meeting NMPA, FDA, and EMA standards.
Global Business Network
Our products and services reach over 40 countries and regions, supporting around 3,000 clients worldwide.